Evidence map›Paper›PMID 29388567›Full record

ReviewNature reviews. Cardiology2018

Nitric oxide signalling in cardiovascular health and disease.

Charlotte Farah, Lauriane Y M Michel, Jean-Luc Balligand

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Cardiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05798481 (A Pilot Pre-Phase 1 Clinical Trial to Study How Administering Sublingual Nitric Oxide Donor S-nitroso-N-acetylcysteine Affects the Systemic Blood Pressure in Healthy Human Volunteers.), which is not on this map. Cited by 339 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
339citing papers in PubMed, 1 pooled it
32.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05798481 early_phase1completednot on this mapstarted 2024, after this paper: background citation

A Pilot Pre-Phase 1 Clinical Trial to Study How Administering Sublingual Nitric Oxide Donor S-nitroso-N-acetylcysteine Affects the Systemic Blood Pressure in Healthy Human Volunteers.

TypeinterventionalSponsorUniversity of Alabama at BirminghamRan2024 to 2025Enrolled14ConditionsHypertension, Cardiovascular DiseasesArmsMixture of Sodium Nitrite and N-acetylcysteine (NAC) crytals.
3 · Its place in the literature

Who cites it

339 citing papers in PubMed, 1 synthesis or guideline pooled it, 752 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. General View of Arachidonic Acid (AA) Metabolism.Reviews of physiology, biochemistry and pharmacology · 2027
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Foods (Basel, Switzerland) · 2026
    Article
  17. Article
  18. Article
  19. Review
  20. Article

279 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Charlotte FarahPole of Pharmacology and Therapeutics (FATH), Institut de Recherche Experimentale et Clinique (IREC) and Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, UCL-FATH Tour Vésale 5th Floor, 52 Avenue Mounier B1.53.09, 1200 Brussels, Belgium.
Lauriane Y M MichelPole of Pharmacology and Therapeutics (FATH), Institut de Recherche Experimentale et Clinique (IREC) and Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, UCL-FATH Tour Vésale 5th Floor, 52 Avenue Mounier B1.53.09, 1200 Brussels, Belgium.
Jean-Luc BalligandPole of Pharmacology and Therapeutics (FATH), Institut de Recherche Experimentale et Clinique (IREC) and Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, UCL-FATH Tour Vésale 5th Floor, 52 Avenue Mounier B1.53.09, 1200 Brussels, Belgium.
UCLouvain · BECliniques Universitaires Saint-Luc · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nitric oxide (NO) signalling has pleiotropic roles in biology and a crucial function in cardiovascular homeostasis. Tremendous knowledge has been accumulated on the mechanisms of the nitric oxide synthase (NOS)-NO pathway, but how this highly reactive, free radical gas signals to specific targets for precise regulation of cardiovascular function remains the focus of much intense research. In this Review, we summarize the updated paradigms on NOS regulation, NO interaction with reactive oxidant species in specific subcellular compartments, and downstream effects of NO in target cardiovascular tissues, while emphasizing the latest developments of molecular tools and biomarkers to modulate and monitor NO production and bioavailability.

Indexed as

Signal TransductionAdenylyl CyclasesAdrenergic beta-3 Receptor AgonistsAnimalsCardiovascular DiseasesCardiovascular SystemEnzyme ActivationEnzyme ActivatorsHumansNitric OxideNitric Oxide DonorsNitric Oxide SynthasePhosphodiesterase 5 InhibitorsReactive Oxygen SpeciesReceptors, Adrenergic, beta-3ADCY10 protein, humanAdenylyl CyclasesADRB3 protein, humanAdrenergic beta-3 Receptor AgonistsEnzyme ActivatorsNitric OxideNitric Oxide DonorsNitric Oxide SynthasePhosphodiesterase 5 InhibitorsReactive Oxygen SpeciesReceptors, Adrenergic, beta-3

Identifiers

PMID29388567
OpenAlexW2785925223

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.